Implementation of the research agenda

Work on the project began on 1 January 2023. The project is innovative in its focus on developing cleaning and disinfecting systems that use the minimum effective concentration of active substances against microorganisms (including antibiotic-resistant bacteria such as the ESKAPE group, which are a major cause of hospital infections), as well as viruses. The ESKAPE group comprises: Enterococcus spp., Staphylococcus aureus, Klebsiella spp., Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.

Research is being carried out using state-of-the-art laboratory equipment.

Suitable raw materials, including non-ionic and anionic surfactants, as well as alkyl polyglucosides, were successfully identified as the basis for a range of cleaning systems.

All raw materials underwent testing for physical and chemical properties and were assessed against a matrix of factors such as CMC, biodegradability, availability, and potential human toxicity. This enabled the Company to select the most appropriate components.

After selecting the target surfactants, work began on developing the most effective cleaning systems, based solely on surfactants, without the addition of auxiliary substances, in order to meet all the defined requirements. This stage was successfully completed, resulting in 5 base cleaning systems. After passing stability tests, the systems were further evaluated for their effectiveness against biofilms, both in removing bacterial biofilms and in reducing their formation.

At present, the Company continues to test the functional properties of the selected systems, including corrosion resistance and dispersion capacity. Prototype cleaning and disinfecting systems are also being assessed for biocidal effectiveness.

The project has been divided into 5 stages, and the Company is now completing one of the final phases.